Sort   by:  
 Page size 
UnknownPharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies.
Not available
S-EPMC3070638 | biostudies-literature
UnknownPhase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours.
Not available
S-EPMC3273358 | biostudies-literature
UnknownSafety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours.
Not available
S-EPMC2844945 | biostudies-literature
UnknownA first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
Not available
S-EPMC9276671 | biostudies-literature
Sort   by:  
 Page size